Patents

US 12605398 B2: CRISPR-based compositions for treating vascular disorders

Granted
2026-04-21
Filed
2020-01-27 application 17425494
Type
Utility · 3 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

CRISPR-based compositions and methods of their use to impair or promote angiogenesis in a patient to treat indications including, but not limited to, tumor growth, age-related macular degeneration, and metastasis. Single-guide ribonucleic acids sg-RNA-1 (SEQ ID NO: 2) or sg-RNA-2 (SEQ ID NO: 3) are shown to affect angiogenesis.

Source: PTBLXML, file of 2026-04-21 (ipgb20260421.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
The Administrators of the Tulane Educational Fund 124 patentsUS company or organizationNew Orleans, LAThe Administrators of the Tulane Educational Fund State business registration EXACT high confidence: identical full name and state
Tulane University of Louisiana College or university EXACT high confidence: through the nonprofit with the college's EIN (identical full name and state)
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-04-21
NATIONAL INSTITUTES OF HEALTH (NIH), U.S DEPT OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 16 patentsUS federal governmentBethesda, MDPTBLXML, file of 2026-04-21

Inventors

InventorPlacePatentsPerson pageSource
Shusheng WangNew Orleans, LA6PTBLXML, file of 2026-04-21
Bo YuNew Orleans, LAPTBLXML, file of 2026-04-21

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/7105PTBLXML, file of 2026-04-21
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N9/22PTBLXML, file of 2026-04-21

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-01-22Government interest
Confirmatory license
TULANE UNIVERSITY OF LOUISIANA signed 2023-11-14NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT BETHESDA, MD66360/212PASDL, file of 2026-10-15
2022-11-14Assignment
Assignment of assignor's interest
WANG, SHUSHENG signed 2022-06-27
YU, BO signed 2022-08-25
THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND NEW ORLEANS, LA61755/523PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.